18FDG-PET in Patients With Melanoma or NSCLC Treated With Immunotherapy

Clinical trial NCT03741231 · COMPLETED

Trial details

NCT number: NCT03741231
Sponsor: University Hospital, Brest
Status: COMPLETED
Study type: OBSERVATIONAL

Melanoma NSCLC Positron-Emission Tomography Immunotherapy 18F-FDG

Start date: 2018-03-01
Primary completion: 2018-06-30
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.